{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-026153","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2022-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.588667+00:00","generated_at":"2026-06-27T05:37:03.279666+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Director Maurice Ferré resigns from MedTech board; Aguero appointed to committees","bullets":["Maurice R. Ferré resigned as director and all positions on Feb 19, 2022; no disagreement with the company.","Manuel Aguero appointed to the Audit and Compensation committees effective upon Ferré's resignation.","Ferré remains Chairman of Memic Innovative Surgery, the target in MedTech's proposed business combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-026153","json":"https://secwatch.observer/filing/0001104659-22-026153.json","markdown":"https://secwatch.observer/filing/0001104659-22-026153.md","text":"https://secwatch.observer/filing/0001104659-22-026153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465922026153/0001104659-22-026153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465922026153/tm227498d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:37:03.279666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d6b62651bd","claim":"Maurice R. Ferré resigned as Director at TriSalus Life Sciences, Inc..","evidence_excerpt":"On February 19 2022, Maurice R. Ferré, MD notified MedTech Acquisition Corporation (“MedTech” or the “Company”) that he was resigning as a member of the Company’s Board of Directors and all other positions with the Company effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000110465922026153/0001104659-22-026153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}